Operating Lease, Payments of ARS Pharmaceuticals, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ARS Pharmaceuticals, Inc. quarterly and annual Operating Lease, Payments in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • ARS Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending 30 Sep 2025 was $141,000, a 127% increase year-over-year.
  • ARS Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1,841,000, a 16% increase from 2020.
Source SEC data
View on sec.gov
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

ARS Pharmaceuticals, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $141,000 +$79,000 +127% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $63,000 +$2,000 +3.3% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $63,000 +$2,000 +3.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 $62,000 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $61,000 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $61,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q3 2022 $1,987,000 $458,000 -$41,000 -8.2% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $2,028,000 $503,000 +$90,000 +22% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $1,938,000 $518,000 +$97,000 +23% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $1,841,000 $508,000 +$99,000 +24% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2022 2021 FY
Q3 2021 $1,742,000 $499,000 +$103,000 +26% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $1,639,000 $413,000 +$24,000 +6.2% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $1,615,000 $421,000 +$24,000 +6% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $1,591,000 $409,000 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $396,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $389,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $397,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1

ARS Pharmaceuticals, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $1,841,000 +$250,000 +16% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2022 2021 FY
2020 $1,591,000 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.